AstraZeneca looks to AI to ease risk in late-stage trials, speed up filingsnews2026-07-27T11:08:17+00:00July 27th, 2026|Endpoints News|
Schrödinger debuts AI agent Bunsen to use its physics softwarenews2026-07-27T11:00:49+00:00July 27th, 2026|Endpoints News|
Roche says it is thoughtful on token use for AI, shelves a drug from Carmot buynews2026-07-23T11:03:14+00:00July 23rd, 2026|Endpoints News|
A-Alpha Bio starts AI antibody data consortium with GSK, Boltznews2026-07-21T11:00:01+00:00July 21st, 2026|Endpoints News|
Anthropic’s life sciences plans: Mystery programs, Nobel hires, M&A and big ambitionnews2026-07-20T15:37:57+00:00July 20th, 2026|Endpoints News|
Bristol Myers, Nvidia say they’ll build ‘most powerful’ AI supercomputer in pharmanews2026-07-20T10:59:51+00:00July 20th, 2026|Endpoints News|
Insilico, Bora Pharma reveal plans for AI-driven manufacturing companynews2026-07-15T12:30:44+00:00July 15th, 2026|Endpoints News|
Chai Discovery gets $400M, tripling valuation from seven months agonews2026-07-14T14:39:45+00:00July 14th, 2026|Endpoints News|
How digital health companies are planning to conquer CMS ACCESSnews2026-07-07T13:00:50+00:00July 7th, 2026|Endpoints News|
Anthropic debuts Claude Science, an AI product for biosciencenews2026-06-30T17:15:35+00:00June 30th, 2026|Endpoints News|
